Irish Life Investment Managers’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Irish Life Investment Managers’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$7.33K	Buy	+2,031	New	+$8.31K	﹤0.01%	1949

Other funds holding IDIX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Irish Life Investment Managers's IDIX Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in IDENIX PHARMACEUTICALS INC (IDIX) in Q2 2013: 2,031 shares worth $7.33K. The stake represents ﹤0.01% of the portfolio and ranks #1949 among its holdings.

97 funds tracked by Wall St. Rank hold IDIX as of Q2 2013.

Irish Life Investment Managers held 2,031 shares of IDENIX PHARMACEUTICALS INC worth $7.33K as of Q2 2013.
IDENIX PHARMACEUTICALS INC was a new Irish Life Investment Managers position in Q2 2013.
IDENIX PHARMACEUTICALS INC made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1949 holding.
97 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.